|
|
|
|
| LEADER |
05673nam a2200601 4500 |
| 001 |
ocn963184472 |
| 003 |
OCoLC |
| 005 |
20180501122033.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
161031s2016 ne o 000 0 eng d |
| 040 |
|
|
|a NLE
|b eng
|e rda
|e pn
|c NLE
|d OCLCF
|d OCLCQ
|d YDX
|d OPELS
|d EBLCP
|d IDEBK
|d N$T
|d MERUC
|d OCLCQ
|d OPELS
|d GrThAP
|
| 019 |
|
|
|a 961010619
|
| 020 |
|
|
|a 9780128052136
|q (electronic bk.)
|
| 020 |
|
|
|a 0128052139
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128047972
|q (hbk.)
|
| 020 |
|
|
|a 0128047976
|
| 035 |
|
|
|a (OCoLC)963184472
|z (OCoLC)961010619
|
| 050 |
|
4 |
|a QR181
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.079
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Advances in immunology.
|n Volume 132 /
|c edited by Frederick Alt.
|
| 264 |
|
1 |
|a Amsterdam :
|b Academic Press,
|c 2016.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in immunology ;
|v volume 132
|
| 506 |
|
|
|a Owing to Legal Deposit regulations this resource may only be accessed from within National Library of Scotland. For more information contact enquiries@nls.uk.
|5 StEdNL
|
| 588 |
0 |
|
|a CIP data; item not viewed.
|
| 505 |
0 |
|
|a Front Cover; Advances in Immunology; Copyright; Contents; Contributors; Chapter One: Context- and Tissue-Specific Regulation of Immunity and Tolerance by Regulatory T Cells; 1. Introduction; 2. Origins of Treg Cells: ``The Third Function of the Thymus (Seddon & Mason, 2000);́́ 3. Suppressive Properties of Treg Cells; 3.1. Suppression of DC Maturation and Function; 3.2. Suppression via Cytolysis; 3.3. Suppression via Metabolic Disruption; 3.4. Suppression Through Secretion of Cytokines; 4. Murine Tissue-Specific Treg Cells; 4.1. Lung-Resident Treg Cells; 4.2. Intestinal Treg Cells.
|
| 505 |
8 |
|
|a 4.3. Visceral Adipose Tissue Treg Cells4.4. Treg Cells in Skeletal Muscle; 4.5. Treg Cells in the Skin; 5. Human Tissue-Resident Treg Cells; 6. Conclusions; References; Chapter Two: Endogenous Retroelements and the Host Innate Immune Sensors; 1. Introduction; 2. Toll-Like Receptors; 3. RIG-I and MDA5; 4. Protein Kinase R; 5. Inflammasome; 6. Conclusion and Perspectives; References; Chapter Three: B-Lymphopoiesis in Fetal Liver, Guided by Chemokines; 1. Introduction; 2. Lineage Choice Between Myeloid and Lymphoid Development; 3. Cytokine Receptor Expressions on Early Progenitors in Fetal Liver.
|
| 505 |
8 |
|
|a 4. Changes of Transcription Factor Expressions and of Hematopoietic Differentiation Capacities During Myeloid/Lymphoid Pr ... 5. B-Cell Development from Early Fetal Liver Progenitors; 6. Nonhematopoietic Mesenchymal Stromal Cells, but not Endothelial Cells, Produce Myeloid-Inducing CSF-1 and Lymphoid-Ind ... ; 7. Selective Chemokines Produced by Endothelium or Mesenchyme Guide Migration of Single Progenitors Expressing Several Ch ... ; 8. Outlook; Acknowledgments; References; Chapter Four: The Roles of the Secreted Phospholipase A2 Gene Family in Immunology; 1. General Aspects of sPLA2s.
|
| 505 |
8 |
|
|a 2. Potential Roles of sPLA2s: Lessons from sPLA2 Transgenic Mice3. Group IIA sPLA2 (PLA2G2A); 3.1. Antibacterial Defense; 3.2. Inflammation; 3.3. Cancer; 3.4. Atherosclerosis; 4. Group IID sPLA2 (PLA2G2D); 4.1. Contact Hypersensitivity; 4.2. Viral Infection; 5. Group IIF sPLA2 (PLA2G2F); 5.1. Psoriasis; 5.2. Skin Cancer; 6. Group III sPLA2 (PLA2G3); 6.1. Anaphylaxis; 6.2. Other Potential Functions; 7. Group V sPLA2 (PLA2G5); 7.1. Macrophage Phagocytosis; 7.2. Th2 Immunity; 7.3. Metabolic Diseases; 7.4. Cardiovascular Diseases; 8. Group X sPLA2 (PLA2G10); 8.1. Asthma and Airway Inflammation.
|
| 505 |
8 |
|
|a 8.2. Colitis8.3. Cardiovascular Diseases, Metabolic Syndrome, and Beyond; 9. Other sPLA2s and sPLA2 Receptor (PLA2R1); 9.1. Other sPLA2s; 9.2. PLA2R1; 10. Perspectives; Acknowledgments; References; Chapter Five: Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses; 1. Type 1 Interferon Signaling During Acute Viral Infection; 1.1. Suppressing Viral Replication/Dissemination; 1.2. Promote Antiviral Immune Responses; 1.3. Augment Pathological Immune Responses; 2. Type I Interferon Signaling and Persistent/Chronic Viral Infection; 2.1. Controlling Virus Replication/Dissemination.
|
| 520 |
|
|
|a Advances in Immunology, Volume 137, the latest in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release including sections on Notch and T-Cell signaling/T-Cell memory, Single Cell Analysis of CD8+ and CD4+ T Cell Differentiation, New Developments in the Chemokine Field, the Role of Caveolin-1 in BCR and TCR Receptors, The Unusual Biochemistry of Bovine Immunoglobulins, and the Molecular Aspects of Allergens and Allergy.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
7 |
|a Immunology.
|2 fast
|0 (OCoLC)fst00968006
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Alt, Frederick W.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 9780128047972
|
| 830 |
|
0 |
|a Advances in immunology ;
|v v. 132.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00652776/132
|z Full Text via HEAL-Link
|
